Responsibility

Sustainability & Responsibility

At IX, responsibility is central to how we operate as a global biopharmaceutical company.

We integrate sustainability, responsible governance, and global public health impact into our strategy to support long-term public health and sustainable development.

Our responsibility framework focuses on three key areas:

  • Environmental stewardship
  • Responsible governance
  • Expanding global access to vaccines

Through these efforts, IX aims to contribute to a healthier and more sustainable future.

Responsibility ct

Environmental Stewardship

IX integrates sustainable practices into its operations to reduce environmental impact while supporting innovation in vaccine manufacturing. Our dedication to sustainability has earned us the prestigious National Green Factory Certification, recognizing our efforts in energy conservation and circular resource utilization.

 

  • Low-Carbon Operations

Advanced energy-efficient systems across manufacturing facilities
These initiatives help reduce energy consumption and support low-carbon manufacturing.

Electricity from clean energy

Electricity from clean energy

132.9
Greenhouse gas emission reduction

Greenhouse gas emission reduction

3709.65

 

  • Water Resource Management

Closed-loop water reuse systems to improve resource efficiency

Water Resource Management

Water Resource Management

40,000+

 

  • Certified Environmental and Safety Standards

IX continuously improves environmental performance while maintaining the highest standards of quality and safety.

ISO 14001

ISO 14001

for Environmental Management

ISO 45001

ISO 45001

for Occupational Health and Safety Management

GMP

GMP

for Good Manufacturing Practices

Responsible Governance

Responsible Governance

Strong governance and transparency are essential to maintaining trust with patients, partners, and regulators.

IX maintains robust governance systems and compliance frameworks aligned with regulatory standards and industry best practices.

ESG Recognition:

  • AA Wind ESG Rating (8.58;#1/151,as of Jan.29,2026)
  • AA China Securities ESG Rating
  • Top 100 ESG Reporting Companies in China (2025)

These recognitions reflect IX’s commitment to responsible management and sustainable growth.

Trade Compliance and Supply Chain Integrity

Trade Compliance and Supply Chain Integrity

As a globally recognized AEO (Authorized Economic Operator) enterprise, IX maintains a comprehensive trade compliance system.

Key areas include:

  • Import and Export Regulatory Compliance
  • Secure and Transparent Global Supply Chains
  • Data Integrity and Regulatory Oversight

These systems support efficient customs clearance and ensure reliable global vaccine supply.

Advancing Global Health

Advancing Global Health

Improving access to vaccines is central to IX’s mission to support global public health.

Through vaccine donations, public health initiatives, and vaccination awareness programs, IX works to expand access to life-saving vaccines, particularly in underserved communities.

ResponsibilityColinCare

Focused on women and family health, we support underprivileged mothers, women and girls, and female employees through public welfare donations and the “ColinCare” Initiative.

$65 M

Total value of donated vaccines

470,000+

Individuals reached

39,000+

Public education campaigns

View More

You Might Also Like

Global Health

Advancing equitable access to vaccines to improve health outcomes worldwide.

Global Health

Compliance

Ensuring the highest standards of ethics, quality, and regulatory adherence.

Compliance

Distribution

Delivering vaccines safely and efficiently through a reliable global network.

Distribution

Compliance Commitment